![Brendan O'Connell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Brendan O'Connell worked as the Vice President-Finance & Controller at BIOLASE, Inc. from 2015 to 2019.
He then served as the Vice President-Finance & Corporate Controller at ReShape Lifesciences, Inc. and ReShape Weightloss, Inc. from 2019 to 2022.
Mr. O'Connell completed his undergraduate degree and MBA at the University of California, Riverside.
Eerdere bekende functies van Brendan O'Connell
| Bedrijven | Functie | Einde |
|---|---|---|
| VYOME HOLDINGS, INC. | Investor Relations Contact | - |
ReShape Weightloss, Inc.
 ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Financieel Directeur/CFO | 30-10-2019 |
| BIOLASE, INC. | Comptroller/Controller/Auditor | 01-05-2019 |
Opleiding van Brendan O'Connell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
43
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
BIOLASE, Inc.
 BIOLASE, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and sells laser systems for dental practitioners & their patients | Health Technology |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReShape Weightloss, Inc.
ReShape Weightloss, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices for the treatment of obesity | Health Technology |
ReShape Lifesciences, Inc.
 ReShape Lifesciences, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of obesity | Health Technology |
Kies MarketScreener 
